Works matching AU Zhu, Xiufang


Results: 51
    1

    The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.

    Published in:
    Emerging Microbes & Infections, 2024, v. 13, n. 1, p. 1, doi. 10.1080/22221751.2024.2320913
    By:
    • Chunhua Zhou;
    • Yuanzheng Qiu;
    • Jianxin Wang;
    • Xiang Zhong;
    • Xiufang Zhu;
    • Xiaojing Huang;
    • Lan Yang;
    • Qiaolei Ji;
    • Feifei Zhou;
    • Shunquan Wu;
    • Mengjie Yang;
    • Jing Zhang;
    • Kaili Liu;
    • Li Ji;
    • Hanyu Yang;
    • Chunlei Li;
    • Yuanyuan Zhao
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50